Lung absorbed doses in radioiodine therapy of thyroid cancer patients with diffuse pulmonary metastases

被引：0
作者：
Liu, Bin [1 ]
Kuang, Anren [1 ]
Rong, Tian [1 ]
机构：
[1] Sichuan Univ, West China Hosp, Dept Nucl Med, Chengdu, Sichuan, Peoples R China
来源：
JOURNAL OF NUCLEAR MEDICINE | 2011年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
180
引用
收藏
页数：1
相关论文
共 50 条
[21]   Functioning pulmonary metastases of thyroid cancer: Does radioiodine influence the prognosis? [J].
Hindie, E ;
Melliere, D ;
Zanotti-Fregonara, P ;
Hallaj, I ;
Kiffel, T ;
deLabriolle-Vaylet, C ;
Askienazy, S .
JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) :145P-145P
[22]   Functioning pulmonary metastases of thyroid cancer: does radioiodine influence the prognosis? [J].
Elif Hindié ;
Didier Mellière ;
Françoise Lange ;
Iyad Hallaj ;
Claire de Labriolle-Vaylet ;
Christian Jeanguillaume ;
Jacques Lange ;
Léon Perlemuter ;
Serge Askienazy .
European Journal of Nuclear Medicine and Molecular Imaging, 2003, 30 :974-981
[23]   Improved prediction of therapeutic absorbed doses of radioiodine in the treatment of thyroid carcinoma [J].
Hermanská, J ;
Kárny, M ;
Zimák, J ;
Jirsa, L ;
Sámal, M ;
Vlcek, P .
JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (07) :1084-1090
[24]   Dosimetry of absorbed doses of Radioiodine-131 in Therapy for Hyperthyroidism [J].
Koshiba, Y. ;
Abe, S. ;
Fujita, N. ;
Nishimoto, T. ;
Sakuragi, Y. ;
Kunimoto, K. ;
Honda, M. ;
Odagawa, T. ;
Kato, K. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 :S641-S641
[25]   RETROSPECTIVE ANALYSIS OF THE COURSE OF THYROID CARCINOMA WITH LUNG METASTASES AFTER RADIOIODINE THERAPY [J].
Astapieva, Olha M. ;
Grushka, Ganna, V ;
Paskevych, Olga, I ;
Fedulenkova, Yuliia Ya ;
Maksimishyn, Oleksii, V .
PERIODICO TCHE QUIMICA, 2020, 17 (35) :728-738
[26]   Radiation absorbed doses and their biological effects in the radioiodine therapy of differentiated thyroid cancer:: A reinvestigation of factors that influence the dosimetry and the therapeutic outcome. [J].
Behr, TM ;
Hötte, P ;
Weber, E ;
Yücekent, S ;
Gratz, S ;
Conrad, M ;
Meller, J ;
Hüfner, M ;
Becker, W .
JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (05) :189P-189P
[27]   Quantification of absorbed doses to urine bladder depending on drinking water during radioiodine therapy to thyroid cancer patients: a clinical study using MIRDOSE3 [J].
Ahmed, ASMS ;
Demir, M ;
Yasar, D ;
Uslu, I .
NUCLEAR MEDICINE COMMUNICATIONS, 2003, 24 (07) :749-754
[28]   VISUALIZATION OF THE THYMUS WITH THERAPEUTIC DOSES OF RADIOIODINE IN PATIENTS WITH THYROID-CANCER [J].
MICHIGISHI, T ;
MIZUKAMI, Y ;
SHUKE, N ;
YOKOYAMA, K ;
NOGUCHI, M ;
WATANABE, Y ;
MATSUI, O ;
ABURANO, T ;
TONAMI, N ;
HISADA, K .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1993, 20 (01) :75-79
[29]   The study of The Biofeedback Therapy on Thyroid cancer patients with Radioiodine Therapy [J].
Liu, Xiaohong ;
Shi, Feng ;
Chai, Wenwen ;
Tang, Haoke ;
Jiang, Ling ;
Yu, Kuizhen ;
Zeng, Li ;
Zhou, Xin .
PSYCHO-ONCOLOGY, 2016, 25 (SP. S3) :148-149
[30]   Efficacy of radioiodine therapy for treating 20 patients with pulmonary metastases from differentiated thyroid cancer and a meta-analysis of the current literature [J].
X. Zhang ;
D.-S. Liu ;
Z.-S. Luan ;
F. Zhang ;
X.-H. Liu ;
W. Zhou ;
S.-F. Zhong ;
H. Lai .
Clinical and Translational Oncology, 2018, 20 :928-935
12345